Condition: Staphylococcus Aureus Endocarditis · Prosthetic Valve Endocarditis · Sponsor: Todd C. Lee MD MPH FIDSA
This is a sub-study of the S. aureus Network Adaptive Platform (SNAP) trial (NCT05137119) wherein we will evaluate whether not giving rifampin in patients with probable or definite prosthetic valve endocarditis due to S. aureus is non-inferior to giving rifampin.
This description comes directly from the study's public registry record.
Lina Petrella · 514-934-1934 · lina.petrella@affiliate.mcgill.ca
Always discuss trial participation with your own doctor first.
| McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital) | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07253688